News

News
Partner news

UK Biobank launches one of the largest scientific studies measuring circulating proteins, to better understand the link between genetics and human disease

Read full story
Partner news

Xencor Enters Collaboration with Janssen with Aim to Discover Novel CD28 Bispecific Antibodies for the Treatment of Prostate Cancer

Read full story
Partner news

Janssen Acquires Rights to Novel Gene Therapy, Pioneering Treatment Solutions for Late-Stage Age-Related Macular Degeneration

Read full story
Partner news

Koa Health to collaborate with Janssen: Official press release

Read full story
Partner news

BioMed X Institute starts new project in immunology research with Janssen

Read full story
Partner news

Alderley Park launches breakthrough Oncology Development Programme in collaboration with Cancer Research UK, Innovate UK, Medicines Discovery Catapult and global pharma and healthcare companies

Read full story
Partner news

BaseLaunch announces that Johnson & Johnson Innovation has renewed its commitment becoming latest strategic partner in the second phase

Read full story
Partner news

ESCAPE Bio Closes $73 Million in Crossover Financing to Advance Clinical Development of Precision Neurology Medicines for Genetic Neurodegeneration

Read full story
Partner news

Rodeo Therapeutics Nominates First-in-Class Oral Development Candidate for Inflammatory Bowel Disease

Read full story
Partner news

GI Windows Raises $16.4M in Series A-1 Financing

Read full story
Partner news

Johnson & Johnson to Acquire Momenta Pharmaceuticals, Inc., Expanding Janssen’s Leadership in Novel Treatments for Autoimmune Diseases

Read full story
Partner news

ImmPACT Bio USA Inc. Raises $18 Million In Series A Financing

Read full story
Partner news

Thirty Madison Raises $47M in Series B Financing From Polaris Partners, Johnson & Johnson Innovation - JJDC, Inc. and Existing Investors

Read full story
Partner news

ViaCyte and Gore Enter Clinical Phase Agreement Based on Novel Membrane Technology for PEC-Encap Product Candidate

Read full story
Partner news

Vor Biopharma Closes $110 Million Series B Financing

Read full story